{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T07:05:58Z","timestamp":1768633558476,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019125","name":"Sorbonne Universit\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019125","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bmcl.2021.128450","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T20:54:34Z","timestamp":1636577674000},"page":"128450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Lipophilic quinolone derivatives: Synthesis and in vitro antibacterial evaluation"],"prefix":"10.1016","volume":"55","author":[{"given":"Elodie","family":"Sadowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Bercot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie","family":"Chauffour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Varon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Mainardis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wladimir","family":"Sougakoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudine","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Sachon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Anquetin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Aubry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.bmcl.2021.128450_b0005","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1021\/jm00186a014","article-title":"Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids","volume":"23","author":"Koga","year":"1980","journal-title":"J Med Chem."},{"issue":"14","key":"10.1016\/j.bmcl.2021.128450_b0010","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1016\/j.bmc.2019.05.038","article-title":"Fluoroquinolones structural and medicinal developments (2013\u20132018): Where are we now?","volume":"27","author":"Suaifan","year":"2019","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2021.128450_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/976273","article-title":"Global fluoroquinolone resistance epidemiology and implictions for clinical use","volume":"2012","author":"Dalhoff","year":"2012","journal-title":"Interdisciplinary Perspectives on Infectious Diseases."},{"issue":"4","key":"10.1016\/j.bmcl.2021.128450_b0020","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1128\/CMR.2.4.378","article-title":"Fluoroquinolone antimicrobial agents","volume":"2","author":"Wolfson","year":"1989","journal-title":"Clin Microbiol Rev."},{"key":"10.1016\/j.bmcl.2021.128450_b0025","unstructured":"World Health Organization. WHO Consolidated Guidelines on Drug-Resistant Tuberculosis Treatment.; 2019. Accessed September 1, 2020. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK539517\/."},{"issue":"10","key":"10.1016\/j.bmcl.2021.128450_b0030","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1128\/JCM.01284-07","article-title":"Antimicrobial Resistance among Gram-Negative Bacilli Causing Infections in Intensive Care Unit Patients in the United States between 1993 and 2004","volume":"45","author":"Lockhart","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128450_b0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.diagmicrobio.2008.04.012","article-title":"Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005\/2006","volume":"62","author":"Zhanel","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.bmcl.2021.128450_b0040","doi-asserted-by":"crossref","unstructured":"Donegan EA, Wirawan DN, Muliawan P, et al. Fluoroquinolone-Resistant Neisseria gonorrhoeae in Bali, Indonesia: 2004. Sexually Transmitted Diseases. 2006;33(10):625-629. doi:10.1097\/01.olq.0000216012.83990.bd.","DOI":"10.1097\/01.olq.0000216012.83990.bd"},{"issue":"7","key":"10.1016\/j.bmcl.2021.128450_b0045","doi-asserted-by":"crossref","first-page":"e1002344","DOI":"10.1371\/journal.pmed.1002344","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action","volume":"14","author":"Wi","year":"2017","journal-title":"PLoS Med."},{"issue":"16","key":"10.1016\/j.bmcl.2021.128450_b0050","doi-asserted-by":"crossref","first-page":"9611","DOI":"10.1093\/nar\/gkx649","article-title":"Activities of gyrase and topoisomerase IV on positively supercoiled DNA","volume":"45","author":"Ashley","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.bmcl.2021.128450_b0055","doi-asserted-by":"crossref","first-page":"a025320","DOI":"10.1101\/cshperspect.a025320","article-title":"Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance","volume":"6","author":"Hooper","year":"2016","journal-title":"Cold Spring Harb Perspect Med."},{"issue":"1","key":"10.1016\/j.bmcl.2021.128450_b0060","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1471-2334-10-196","article-title":"Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital","volume":"10","author":"Dent","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10.1016\/j.bmcl.2021.128450_b0065","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1128\/AAC.00750-12","article-title":"Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of pseudomonas aeruginosa bacteremia","volume":"56","author":"Morata","year":"2012","journal-title":"Antimicrob Agents Chemother."},{"issue":"9","key":"10.1016\/j.bmcl.2021.128450_b0070","doi-asserted-by":"crossref","first-page":"1800141","DOI":"10.1002\/ardp.201800141","article-title":"Recent updates of fluoroquinolones as antibacterial agents","volume":"351","author":"Ezelarab","year":"2018","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmcl.2021.128450_b0075","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ejmech.2018.01.080","article-title":"Fluoroquinolone derivatives and their anti-tubercular activities","volume":"146","author":"Fan","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128450_b0080","unstructured":"Grohe K, Petersen U, Kuck K-H. MICROBICIDAL AGENTS BASED ON QUINOLONECARBOXYLIC ACID. Published online 1986. Accessed June 15, 2020. https:\/\/patentimages.storage.googleapis.com\/01\/64\/be\/a2e9540afd7cca\/US4563459.pdf."},{"issue":"4","key":"10.1016\/j.bmcl.2021.128450_b0085","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/jac\/33.4.685","article-title":"Structure-activity and structure-side-effect relationships for the quinolone antibacterials","volume":"33","author":"Domagala","year":"1994","journal-title":"J Antimicrob Chemother."},{"issue":"7","key":"10.1016\/j.bmcl.2021.128450_b0090","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1021\/jm00059a012","article-title":"Quinolone antibacterials containing the new 7-[3-(1-aminoethyl)-1-pyrrolidinyl] side chain: the effects of the 1-aminoethyl moiety and its stereochemical configurations on potency and in vivo efficacy","volume":"36","author":"Domagala","year":"1993","journal-title":"J Med Chem."},{"issue":"5","key":"10.1016\/j.bmcl.2021.128450_b0095","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1021\/jm301650g","article-title":"Design, Synthesis, and Biological Evaluations of Novel 7-[7-Amino-7-methyl-5-azaspiro[2.4]heptan-5-yl]-8-methoxyquinolines with Potent Antibacterial Activity against Respiratory Pathogens","volume":"56","author":"Odagiri","year":"2013","journal-title":"J Med Chem."},{"issue":"7","key":"10.1016\/j.bmcl.2021.128450_b0100","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1021\/jm00007a017","article-title":"7-Azetidinylquinolones as Antibacterial Agents. 3. Synthesis, Properties and Structure-Activity Relationships of the Stereoisomers Containing a 7-(3-Amino-2-methyl-1-azetidinyl) Moiety","volume":"38","author":"Frigola","year":"1995","journal-title":"J Med Chem."},{"issue":"1","key":"10.1016\/j.bmcl.2021.128450_b0105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bmc.2017.11.030","article-title":"Design, synthesis and evaluation against Mycobacterium tuberculosis of azole piperazine derivatives as dicyclotyrosine (cYY) mimics","volume":"26","author":"El-wahab","year":"2018","journal-title":"Bioorg Med Chem"},{"issue":"3","key":"10.1016\/j.bmcl.2021.128450_b0110","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1128\/AAC.34.3.496","article-title":"Influence of N substitution on antimycobacterial activity of ciprofloxacin","volume":"34","author":"Haemers","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.bmcl.2021.128450_b0115","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2174\/157340609789117859","article-title":"Antibacterial Activity of Lipophilic Fluoroquinolone Derivatives","volume":"5","author":"de Almeida","year":"2009","journal-title":"MC."},{"key":"10.1016\/j.bmcl.2021.128450_b0120","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejmech.2013.06.045","article-title":"Microwave assisted synthesis of some hybrid molecules derived from norfloxacin and investigation of their biological activities","volume":"67","author":"Mentese","year":"2013","journal-title":"Eur J Med Chem"},{"issue":"5","key":"10.1016\/j.bmcl.2021.128450_b0125","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3390\/molecules22050841","article-title":"Synthesis of 1,2,3-Triazolo[4,5-h]quinolone Derivatives with Novel Anti-Microbial Properties against Metronidazole Resistant Helicobacter pylori","volume":"22","author":"Abu-Sini","year":"2017","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128450_b0130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cclet.2014.09.017","article-title":"Synthesis and antibacterial activity of novel [1,2,4]triazolo[3,4-h][1,8]naphthyridine-7-carboxylic acid derivatives","volume":"26","author":"Gao","year":"2015","journal-title":"Chin Chem Lett"},{"issue":"25","key":"10.1016\/j.bmcl.2021.128450_b0135","doi-asserted-by":"crossref","first-page":"13991","DOI":"10.1073\/pnas.94.25.13991","article-title":"DNA topoisomerase targets of the fluoroquinolones: A strategy for avoiding bacterial resistance","volume":"94","author":"Zhao","year":"1997","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"10.1016\/j.bmcl.2021.128450_b0140","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/jhet.1927","article-title":"Synthesis, Characterization, and Antimicrobial Activities of Novel N-substituted \u03b2-Hydroxy Amines and \u03b2-Hydroxy Ethers that Contained 8-Methoxy Fluoroquinolones","volume":"53","author":"Guruswamy","year":"2016","journal-title":"J Heterocycl Chem"},{"issue":"12","key":"10.1016\/j.bmcl.2021.128450_b0145","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.ejmech.2006.07.003","article-title":"Design, synthesis and activity against Toxoplasma gondii, Plasmodium spp., and Mycobacterium tuberculosis of new 6-fluoroquinolones","volume":"41","author":"Anquetin","year":"2006","journal-title":"Eur J Med Chem"},{"issue":"10","key":"10.1016\/j.bmcl.2021.128450_b0150","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1128\/AAC.45.10.2703-2709.2001","article-title":"Enhancement of Fluoroquinolone Activity by C-8 Halogen and Methoxy Moieties: Action against a Gyrase Resistance Mutant of Mycobacterium smegmatis and a Gyrase-Topoisomerase IV Double Mutant of Staphylococcus aureus","volume":"45","author":"Lu","year":"2001","journal-title":"Antimicrob Agents Chemother."},{"issue":"8","key":"10.1016\/j.bmcl.2021.128450_b0155","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.tim.2014.04.007","article-title":"Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success","volume":"22","author":"Redgrave","year":"2014","journal-title":"Trends Microbiol"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21006776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21006776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:42:34Z","timestamp":1760773354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X21006776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":31,"alternative-id":["S0960894X21006776"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128450","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipophilic quinolone derivatives: Synthesis and in vitro antibacterial evaluation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128450","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128450"}}